Organ failure in acute pancreatitis

Journal of Organ Dysfunction

Volumn 2, Issue 3, 2006, Pages 171-175

  Johnson, C D ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acute pancreatitis; Organ failure; Pancreatic necrosis; Systemic inflammatory response syndrome

Indexed keywords

ACUTE PANCREATITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MORTALITY; MULTIPLE ORGAN FAILURE; PANCREAS INJURY; PANCREAS NECROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33748453016     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060600833295     Document Type: Review

References (12)

1. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-90.
2. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
3. Le Mee J, Paye F, Sauvanet A, et al. Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg 2001;136:1386-90.
4. Formela LJ, Galloway SW, Kingsnorth AN. Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
5. Wereszczynska-Siemiatkowska U, Dabrowski A, Siemiatkowski A, et al. Serum profiles of E-selectin, interleukin-10, and interleukin-6 and oxidative stress parameters in patients with acute pancreatitis and nonpancreatic acute abdominal pain. Pancreas 2003;26:144-52.
6. Andersson R, AJNGWX. Gut barrier failure in critical illness: lessons learned from acute pancreatitis. Scand J Organ Dysfunct 2006;2:93-100.
7. Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;48:62-9.
8. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995;82:1414-20.
9. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001;22:274-8.
10. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-4.
11. Buter A, Imrie CW, Carter CR, et al. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002;89:298-302.
12. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999;86:1020-4.